Michal Laufer Perl, Isreal
Director of the Cardiovascular Clinics and Head of the Heart Failure service at Tel Aviv Sourasky Medical Center, Israel
- Director of the Cardiovascular Clinics and Head of the Heart Failure service at Tel Aviv Sourasky Medical Center, Israel.
- Clinical Associate Professor, Gray Faculty of Medicine, Cardiology Department, Tel Aviv University, Israel.
- Master of Health Administration (MHA), Ben Gurion University, Israel.
- Observational Rotation in Cardio-oncology, Memorial Sloan Kettering Cancer Center, New York, USA (2016).
- Secretary of the Cardiomyopathy Section of the Israel Cardiology Association (2021-2025).
- Fellow of the ESC (FESC) and a fellow of the ESC HFA (FHFA).
- ESC “Heart Failure Specialists of Tomorrow” (HoT) (2018-2021).
- ESC HFA Committee Member on the Heart Failure Matters Committee and the Scientific Committee on Cardio-Oncology (2024-2026).
- Completed the ACC Global Leadership Institute.
- Deliver regulatory lectures and abstract presentations (47 abstracts) at national and international conferences; serve as the ACC 2026 Jeopardy leadership writer; and serve as a faculty participant in the ICI, ESC HFA and ESC conferences.
- Member of the Cardiology Board Examination Question-Writing Committee.
- Principal investigator in several multicenter cardiovascular trials like RELIEVE-HF, ALLAY, CORDIO, and PULNOVO.
- I secured approximately USD 500,000 in research funding.
- Published over 80 papers in highly prestigious journals in the field of cardiovascular.
- Reviewer (Lancet, JACC) and section editor of several leading international cardiovascular journals.
Lectures：
Session 6: The Link Between Heart Failure and Kidney Disease: How to Face in Diabetes?Session 8: The Effect of GLP-1RA on CVD